20+ Years of Healthcare Transformation

Dr. Goldsteen is the co-founder of VigiLanz, and serves as Chairman and CEO. He is a founder and former Chairman and CEO of Vascular Science, Inc., purchased by St. Jude Medical (NASDAQ:STJ). He is the founder and Managing Partner of Global Capital Investments, LLC, a boutique merchant banking group. He previously served as a board member/financier of SurVivaLink, a medical device manufacturer sold to Cardiac Science (NASDAQ:DFIB), MediaDVX, a digital media provider sold to NetStar LP, InfoPet, a veterinary microchipping company, and Quantech, Ltd, a medical diagnostics company. From 1988–1993 he served as Vice President of Medical Affairs for Emergency Services at Health One, a predecessor of Allina Hospitals and Clinics, a diversified healthcare delivery organization. Dr. Goldsteen is a graduate of the University of Minnesota Medical School, performing his residency in Internal Medicine at Hennepin County Medical Center in Minneapolis, MN. He received board certifications in internal medicine and emergency medicine. He received his M.B.A. in 1994 from the Carlson School of Management at the University of Minnesota.

David Abelson, MD has had a career in medicine, health system design, and executive leadership. David trained in general internal medicine and after a time in private practice joined a large integrated delivery system, Park Nicollet Health Services. In 2010 David became CEO of Park Nicollet Health Services and led the direction of Park Nicollet to value-based payment resulting in a merger with HealthPartners in 2013. As Senior Vice President of HealthPartners and CEO of Park Nicollet, David led a delivery system with multiple hospitals, clinics and specialties with a combined annual revenue of $2.2 billion. David retired in 2014 and is now President of the Institute for Clinical Systems Improvement.

Jeff Zalasky, JD served as General Counsel for VigiLanz until his retirement in 2014 and currently serves as an observer of the board of directors. He is a vice president of Global Capital Investments, LLC, a boutique merchant banking group. Jeff served on the board of Vascular Science, Inc. prior to its acquisition by St. Jude Medical in 1999, and he was a board observer for MediaDVX. Jeff received his law degree from Hamline University School of Law in St. Paul, Minnesota.

Dr. Klass is the developer of VigiLanz’s prototype technology and served as Chief Medical Officer from the company’s founding in 2001 through his retirement in 2014. He has had a long-term interest in the logic of pharmacy ordering systems and the relation of these systems to laboratory results and the creation of tools that could mine and combine both systems intelligently. Dr. Klass graduated from the University of Manitoba and the University of Chicago. He lives in Spain and Chicago.

David Orbuch is a values-based leader that has successfully led businesses on three continents. David achieves results by leveraging the power of strong and diverse teams, relentlessly focusing on operational excellence, and recognizing that a healthy corporate culture is a sustainable competitive advantage. His core leadership strengths include, financial management, strategy development, business planning, and operational execution. David is also a recognized leader in the area of governance, corporate responsibility and health care compliance